Drug intelligence / Profile preview

MUC1 shRNA

Development stage
Preclinical
Lead developer
Inserm
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

MUC1 shRNA is a short hairpin RNA designed to silence the expression of the Mucin 1 (MUC1) protein. MUC1 is a membrane-bound glycoprotein that is frequently overexpressed in various cancers, including clear-cell renal cell carcinoma (cRCC), where it correlates with tumor progression, metastasis, and chemoresistance. By targeting MUC1 mRNA for degradation via the RNA interference (RNAi) pathway, MUC1 shRNA reduces MUC1 protein levels, leading to decreased cell invasion, migration, and anchorage-independent growth in preclinical models. While primarily used as a research tool to validate MUC1 as a therapeutic target, shRNA-based approaches represent a potential modality for gene therapy in oncology.

Other names
shRNA targeting MUC1MUC1-shRNAMUC-1-shRNAMUC 1-shRNA
02

Targets

MUC1 (Mucin-1 Antigen)

Beyond the preview

Go deeper on MUC1 shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MUC1 shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call